• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于监测、流行病学和最终结果(SEER)数据库的鼻腔鳞状细胞癌预后模型的开发与验证

Development and validation of a prognostic model for nasal cavity squamous cell carcinoma based on the SEER database.

作者信息

Zeng Qiwei, Sheng Ming, Ouyang Si, Liu Bin

机构信息

Department of Otorhinolaryngology - Head and Neck Surgery, The First Affiliated Hospital of Hunan Normal University Hunan Provincial People's Hospital, Changsha, 410005, China.

出版信息

Sci Rep. 2025 Jul 24;15(1):26939. doi: 10.1038/s41598-025-10355-w.

DOI:10.1038/s41598-025-10355-w
PMID:40707549
Abstract

This study sought to construct and validate a prognostic nomogram for predicting cause-specific survival (CSS) in patients with nasal cavity squamous cell carcinoma (NCSCC). We conducted a retrospective analysis of clinical data from NCSCC patients registered in the SEER database between 2007 and 2015. Statistical analyses were performed to assess CSS rates and identify prognostic factors. The study cohort comprised 580 NCSCC patients, with CSS probabilities of 89.1%, 74.8%, and 63.6% at 1, 3, and 5 years, respectively. Multivariate Cox regression analysis identified age, American Joint Committee on Cancer (AJCC) stage, and radiotherapy administration as independent prognostic factors significantly associated with CSS. The accuracy of the prediction was evaluated using the C-index and calibration curve. Decision curve analysis (DCA) was utilized to compare the nomogram with the AJCC stage system in order to assess its superiority. We developed and validated a predictive model for 1-, 3-, and 5-year CSS in NCSCC based on a large retrospective cohort. The nomogram demonstrates clinical utility in guiding individualized treatment strategies and patient management.

摘要

本研究旨在构建并验证一种用于预测鼻腔鳞状细胞癌(NCSCC)患者特定病因生存率(CSS)的预后列线图。我们对2007年至2015年期间在监测、流行病学和最终结果(SEER)数据库中登记的NCSCC患者的临床数据进行了回顾性分析。进行统计分析以评估CSS率并确定预后因素。研究队列包括580例NCSCC患者,其1年、3年和5年的CSS概率分别为89.1%、74.8%和63.6%。多因素Cox回归分析确定年龄、美国癌症联合委员会(AJCC)分期和放疗使用情况为与CSS显著相关的独立预后因素。使用C指数和校准曲线评估预测的准确性。采用决策曲线分析(DCA)将列线图与AJCC分期系统进行比较,以评估其优越性。我们基于一个大型回顾性队列开发并验证了一种用于预测NCSCC患者1年、3年和5年CSS的预测模型。该列线图在指导个体化治疗策略和患者管理方面具有临床实用性。

相似文献

1
Development and validation of a prognostic model for nasal cavity squamous cell carcinoma based on the SEER database.基于监测、流行病学和最终结果(SEER)数据库的鼻腔鳞状细胞癌预后模型的开发与验证
Sci Rep. 2025 Jul 24;15(1):26939. doi: 10.1038/s41598-025-10355-w.
2
A SEER-based prognostic nomogram for early-stage (pT1-2N0M0) tongue squamous cell carcinoma and an observational analysis of postoperative radiotherapy.基于监测、流行病学与最终结果(SEER)数据库的早期(pT1-2N0M0)舌鳞状细胞癌预后列线图及术后放疗的观察性分析
World J Surg Oncol. 2025 Jul 25;23(1):302. doi: 10.1186/s12957-025-03883-2.
3
A Nomogram for Predicting Cancer-Specific Survival in Patients With Stage I Vulvar Squamous Cell Carcinoma: A Study Based on the SEER Database and External Validation.预测Ⅰ期外阴鳞状细胞癌患者癌症特异性生存的列线图:一项基于监测、流行病学和最终结果(SEER)数据库及外部验证的研究
Cancer Control. 2025 Jan-Dec;32:10732748251357144. doi: 10.1177/10732748251357144. Epub 2025 Jul 2.
4
Comprehensive study of clinical features, prognostic factors, and survival in patients with pancreatic solid pseudopapillary neoplasms based on the 2019 WHO classification.基于 2019 年 WHO 分类的胰腺实性假乳头状瘤患者临床特征、预后因素和生存的综合研究。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12393-12404. doi: 10.1007/s00432-023-04982-x. Epub 2023 Jul 13.
5
Development and validation of nomograms for predicting survival of locally advanced rectosigmoid junction cancer patients: a SEER database analysis.预测局部晚期直肠乙状结肠交界处癌患者生存的列线图的开发与验证:一项监测、流行病学和最终结果(SEER)数据库分析
Transl Cancer Res. 2025 May 30;14(5):2808-2821. doi: 10.21037/tcr-24-1810. Epub 2025 May 27.
6
Identification of Patients with Early-Stage Hepatocellular Carcinoma Benefiting from Neoadjuvant Chemotherapy-A SEER-Based Study.基于监测、流行病学和最终结果(SEER)数据库研究:识别从新辅助化疗中获益的早期肝细胞癌患者
J Gastrointest Cancer. 2025 Jun 29;56(1):144. doi: 10.1007/s12029-025-01264-2.
7
Nomogram for the prediction of the prognosis of patients with triple-negative invasive ductal carcinoma of breast after neoadjuvant chemotherapy.用于预测三阴性浸润性乳腺癌患者新辅助化疗后预后的列线图。
Sci Rep. 2025 Jul 1;15(1):21666. doi: 10.1038/s41598-025-05738-y.
8
A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.原发性鳞状细胞甲状腺癌患者预后预测的竞争风险列线图
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241254059. doi: 10.1177/15330338241254059.
9
Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.用于预测非转移性鼻咽癌生存结局并指导治疗的两个基于网络的动态交互式列线图和风险分层系统。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15969-15987. doi: 10.1007/s00432-023-05363-0. Epub 2023 Sep 8.
10
A novel nomogram for survival prediction in renal cell carcinoma patients with brain metastases: an analysis of the SEER database.一种用于预测肾细胞癌脑转移患者生存情况的新型列线图:基于监测、流行病学和最终结果(SEER)数据库的分析
Front Immunol. 2025 Jun 30;16:1572580. doi: 10.3389/fimmu.2025.1572580. eCollection 2025.

本文引用的文献

1
A Meta-Analysis on the Impact of Induction Chemotherapy on Survival Outcomes for Sinonasal Squamous Cell Carcinoma.诱导化疗对鼻窦鳞状细胞癌生存结局影响的Meta分析
J Rhinol. 2025 Mar;32(1):10-16. doi: 10.18787/jr.2025.00001. Epub 2025 Mar 21.
2
Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study.帕博利珠单抗联合化疗治疗复发性或转移性鼻腔及鼻窦鳞状细胞癌患者:一项前瞻性II期研究
Clin Cancer Res. 2025 May 1;31(9):1636-1643. doi: 10.1158/1078-0432.CCR-24-4148.
3
Endoscopic surgery for squamous cell carcinoma in the nasal cavity and ethmoid sinus: A retrospective observational study.
鼻腔和筛窦鳞状细胞癌的内镜手术:一项回顾性观察研究。
Auris Nasus Larynx. 2024 Dec;51(6):996-1002. doi: 10.1016/j.anl.2024.10.006. Epub 2024 Oct 19.
4
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment.鼻腔和鼻窦癌:诊断与治疗。
Curr Oncol Rep. 2024 Sep;26(9):1057-1069. doi: 10.1007/s11912-024-01566-x. Epub 2024 Jun 27.
5
Population-based Long-term Outcomes for Squamous Cell Carcinoma of the Nasal Cavity.鼻腔鳞状细胞癌的基于人群的长期预后。
Am J Clin Oncol. 2023 May 1;46(5):199-205. doi: 10.1097/COC.0000000000000992. Epub 2023 Mar 8.
6
The role of elective neck dissection in T1 and T2 nasal cavity squamous cell carcinomas.选择性颈部解剖在 T1 和 T2 鼻腔鳞状细胞癌中的作用。
Eur Arch Otorhinolaryngol. 2023 Apr;280(4):1875-1883. doi: 10.1007/s00405-022-07718-8. Epub 2022 Nov 7.
7
Clinicopathological Challenges in Tumors of the Nasal Cavity and Paranasal Sinuses: Our Experience.鼻腔和鼻窦肿瘤的临床病理挑战:我们的经验
Cureus. 2022 Sep 13;14(9):e29128. doi: 10.7759/cureus.29128. eCollection 2022 Sep.
8
Nasal Cavity Squamous Cell Carcinoma: Factors Associated With Treatment Outcomes and Potential Organ Preservation.鼻腔鳞状细胞癌:与治疗结果相关的因素及潜在的器官保存。
Am J Rhinol Allergy. 2023 Jan;37(1):35-42. doi: 10.1177/19458924221130133. Epub 2022 Oct 2.
9
A Case of Squamous Cell Carcinoma of the Nasal Cavity Treated With Total Rhinectomy.一例鼻腔鳞状细胞癌行全鼻切除术治疗的病例
Cureus. 2022 Mar 28;14(3):e23576. doi: 10.7759/cureus.23576. eCollection 2022 Mar.
10
Conditional and Overall Disease-Specific Survival in Patients With Paranasal Sinus and Nasal Cavity Cancer: Improved Outcomes in the Endoscopic Era.条件性和总体疾病特异性生存率在鼻窦和鼻腔癌症患者中:内镜时代的改善结果。
Am J Rhinol Allergy. 2022 Jan;36(1):57-64. doi: 10.1177/19458924211019158. Epub 2021 May 17.